Matches in Wikidata for { <http://www.wikidata.org/entity/Q80587543> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q80587543 description "article scientifique publié en 2007" @default.
- Q80587543 description "artículu científicu espublizáu en mayu de 2007" @default.
- Q80587543 description "scientific article published on 01 May 2007" @default.
- Q80587543 description "wetenschappelijk artikel" @default.
- Q80587543 description "наукова стаття, опублікована в травні 2007" @default.
- Q80587543 name "The effects of repeat omalizumab administration on skin test positivity and the assessment of the safety of administration in patients with positive skin tests to mouse antigen" @default.
- Q80587543 name "The effects of repeat omalizumab administration on skin test positivity and the assessment of the safety of administration in patients with positive skin tests to mouse antigen" @default.
- Q80587543 type Item @default.
- Q80587543 label "The effects of repeat omalizumab administration on skin test positivity and the assessment of the safety of administration in patients with positive skin tests to mouse antigen" @default.
- Q80587543 label "The effects of repeat omalizumab administration on skin test positivity and the assessment of the safety of administration in patients with positive skin tests to mouse antigen" @default.
- Q80587543 prefLabel "The effects of repeat omalizumab administration on skin test positivity and the assessment of the safety of administration in patients with positive skin tests to mouse antigen" @default.
- Q80587543 prefLabel "The effects of repeat omalizumab administration on skin test positivity and the assessment of the safety of administration in patients with positive skin tests to mouse antigen" @default.
- Q80587543 P1433 Q80587543-B6B00C05-E250-4F49-8A72-D144AD28730C @default.
- Q80587543 P1476 Q80587543-6162F68E-BEDD-41B6-B315-5F3117727359 @default.
- Q80587543 P2093 Q80587543-145726E6-B142-40D4-B7DB-722716F37429 @default.
- Q80587543 P2093 Q80587543-7810535A-C814-4280-A110-2713B776BDD4 @default.
- Q80587543 P304 Q80587543-7283FA77-7D65-4EF0-BC04-4E2927CA524C @default.
- Q80587543 P31 Q80587543-40D3EFBF-BC73-4F8D-A941-CE75E63C86E3 @default.
- Q80587543 P356 Q80587543-2B39F81F-D7F1-4C35-8DBF-B730CED6C1F6 @default.
- Q80587543 P433 Q80587543-4B87B260-75A1-4A28-B1ED-933841B0332D @default.
- Q80587543 P478 Q80587543-03EE5014-6E5A-47EF-BD19-8D3363DE2AEA @default.
- Q80587543 P577 Q80587543-C52F56B7-F70F-4454-B3F1-DEAEBC6C6452 @default.
- Q80587543 P698 Q80587543-98EC6D73-96C3-4DF3-A707-2E3A9113525C @default.
- Q80587543 P356 AAP.2007.28.3005 @default.
- Q80587543 P698 17619561 @default.
- Q80587543 P1433 Q2522351 @default.
- Q80587543 P1476 "The effects of repeat omalizumab administration on skin test positivity and the assessment of the safety of administration in patients with positive skin tests to mouse antigen" @default.
- Q80587543 P2093 "Mathew Varghese" @default.
- Q80587543 P2093 "Phil Lieberman" @default.
- Q80587543 P304 "320-323" @default.
- Q80587543 P31 Q13442814 @default.
- Q80587543 P356 "10.2500/AAP.2007.28.3005" @default.
- Q80587543 P433 "3" @default.
- Q80587543 P478 "28" @default.
- Q80587543 P577 "2007-05-01T00:00:00Z" @default.
- Q80587543 P698 "17619561" @default.